Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment – Sarepta Therapeutics

Written by

admin

in

  1. Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment  Sarepta Therapeutics
  2. Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor  BioSpace
  3. Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics  Business Wire
  4. Sarepta sells $174 million in Arrowhead stock, triggers $100 million milestone  StreetInsider

Continue Reading

More posts